Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | ANO1 | Q5XXA6 | 2/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6760062 | 0.94 | ALDH1A1 (0.45) | ALDH1A1LMNAMAPTUSP30GPR119 | |
| SCHEMBL17140249 | 0.81 | ALDH1A1 (0.49) | NPBWR1MCHR1ALDH1A1LMNAMAPT | |
| SCHEMBL2088384 | 0.78 | ALDH1A1 (0.50) | ALDH1A1LMNAMAPTUSP30GPR119 | |
| SCHEMBL6761275 | 0.77 | F10 (0.45) | LMNAUSP30 | |
| SCHEMBL31043946 | 0.77 | LMNA (0.52) | ALDH1A1LMNAMAPTGPR119SCN9A | |
| SCHEMBL6760101 | 0.77 | USP30 (0.51) | ALDH1A1MAPTUSP30GPR119ANO1 | |
| SCHEMBL6764207 | 0.76 | ALDH1A1 (0.47) | ALDH1A1LMNAMAPTUSP30SLC6A9 | |
| SCHEMBL6764208 | 0.76 | ALDH1A1 (0.47) | ALDH1A1LMNAMAPTUSP30SLC6A9 | |
| SCHEMBL30523709 | 0.76 | GPR119 (0.52) | ALDH1A1GPR119DPP4 | |
| SCHEMBL20766541 | 0.76 | GPR119 (0.52) | ALDH1A1GPR119DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040147545-A1 | Derivatives of oxazolidinones as antibacterial agents | LABORATORIOS VITA, S.A. (ES) | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147545-A1 | Derivatives of oxazolidinones as antibacterial agents | OXA1L, Q6ZSR9, PGC | NPBWR1 3843/4885MCHR1 4199/4885ALDH1A1 1970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.